about
Interactions of AChE with Aβ Aggregates in Alzheimer's Brain: Therapeutic Relevance of IDN 5706Memoquin: a multi-target-directed ligand as an innovative therapeutic opportunity for Alzheimer's diseaseNovel 16-substituted bifunctional derivatives of huperzine B: multifunctional cholinesterase inhibitors.Targeting acetylcholinesterase to treat neurodegeneration.Huprines for Alzheimer's disease drug development.Chemical and pharmacological studies on enantiomerically pure p-methoxytacripyrines, promising multi-target-directed ligands for the treatment of Alzheimer's disease.Highly selective inhibition of butyrylcholinesterase by a novel melatonin-tacrine heterodimers.Colletotrichine A, a new sesquiterpenoid from Colletotrichum gloeosporioides GT-7, a fungal endophyte of Uncaria rhynchophylla.New 2-Aryl-9-methyl-β-carbolinium salts as Potential Acetylcholinesterase Inhibitor agents: Synthesis, Bioactivity and Structure-Activity Relationship.The bivalent ligand approach as a tool for improving the in vitro anti-Alzheimer multitarget profile of dimebon.Evaluation of multifunctional synthetic tetralone derivatives for treatment of Alzheimer's disease.Two new compounds, deacetylisowortmins A and B, isolated from an endophytic Fungus, Talaromyces wortmannii LGT-4.Lycodine-type alkaloids from Lycopodiastrum casuarinoides and their acetylcholinesterase inhibitory activity.5-Methyl--(8-(5,6,7,8-tetrahydroacridin-9-ylamino)octyl)-5-indolo[2,3-]quinolin-11-amine: a highly potent human cholinesterase inhibitor
P2860
Q21129335-BA5220DB-B25B-4DF0-9672-1F17E2C06752Q28820783-02E53A86-1400-4D93-92AE-3D65F6533D83Q33552783-470B56B8-47D9-4C4C-8296-7D70B5EE8DF9Q36709537-BDDF06DF-6DE3-43B0-A935-E858919930B4Q38088283-7F3B2CBB-29AC-4989-9944-209C3B4F7674Q39459684-86D33AA8-DB5F-4B54-865A-3C28936DDBA8Q43747390-5337A0DC-2812-41D1-B56D-BD63B4A5527CQ47798346-3A3FC739-7D11-4FA8-9513-6A863C85AA30Q49703452-A7065312-D6AA-4DAC-A0F1-B6EBB50CADEBQ50859830-9D339195-AA7D-4F6F-A45D-A64FD690E235Q51109990-C568DDF1-BC28-4630-8426-3EF00D896217Q51577238-CF573F90-36CF-46DD-9BE4-744221028AB6Q53504457-5BB1C3CE-3B2D-4135-8236-EF8DE6C17DE5Q56960330-D4751FDF-6E17-43F4-80ED-611C4800E838
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Dimeric and hybrid anti-Alzheimer drug candidates.
@ast
Dimeric and hybrid anti-Alzheimer drug candidates.
@en
type
label
Dimeric and hybrid anti-Alzheimer drug candidates.
@ast
Dimeric and hybrid anti-Alzheimer drug candidates.
@en
prefLabel
Dimeric and hybrid anti-Alzheimer drug candidates.
@ast
Dimeric and hybrid anti-Alzheimer drug candidates.
@en
P1476
Dimeric and hybrid anti-Alzheimer drug candidates.
@en
P2093
D Muñoz-Torrero
P304
P356
10.2174/092986706775527974
P50
P577
2006-01-01T00:00:00Z